Company / Free Cash Flow
IMMUCELL CORP /DE/ Free Cash Flow History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$107.8K
FY2025
5-year range
-$6.6M / $181.0K
FY2021-FY2025
Trend
+98.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow returned to growth in FY2025 after 4 years of decline, reaching -$107,822.
Based on SEC 10-K filings.
-$107,822 in FY2025.
Improved from -$6M to -$107,822 over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 98.4% year-over-year.
- Peak free cash flow was recorded in FY2015.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$107.8K | +98.4% |
| FY2024 | -$6.6M | -19.0% |
| FY2023 | -$5.5M | -44.9% |
| FY2017 | -$3.8M | -2203.7% |
| FY2016 | $181.0K | -63.9% |
| FY2015 | $501.0K | +626.1% |
| FY2014 | $69.0K | +124.5% |
| FY2013 | -$281.1K | +69.6% |
| FY2012 | -$925.2K | -62.5% |
| FY2011 | -$569.2K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026